Breakthrough Cancer Research

We are committed to working in partnership with collaborators both national and international to accelerate the progress of research toward the development of new cancer treatments.  Through fostering innovation and sharing best practice, we are advancing cancer research which is truly world-class.

We are proud to work in collaboration with the following organisations:

Irish Collaborators Include:

• Beaumont Hospital, Dublin
• Dept. of Pathology, UCC
• Dept. of Pharmacology, UCC
• Dept. of Physiology, UCC
• Moyne Institute of Preventive Medicine,
• Trinity College Dublin
• National Cancer Registry of Ireland
• National Food Biotechnology Centre, Cork
• NUI Galway
• Queens University Belfast
• Royal College of Surgeons in Ireland, Dublin
• The School of Pharmacy – ABC Centre, Cork
• Tyndall Institute (formerly NMRC), Cork
• University College Dublin / Dublin City University / St. Vincent’s Hospital
• University of Ulster, Biomedical Sciences Institute, Coleraine, Northern Ireland

International Collaborators Include:

• Aditus Medical, Lund, Sweden
• Cancer Research UK, London
• The Royal Marsden, UK
• Weill Cornell Medical College, New York, USA
• New York University Langone, New York, USA
• Cold Spring Harbor, NY, USA
• Dept. of Oncology, Herlev Hospital, Copenhagen, Denmark
• Ecole Polytechnique Federale de Lausanne, Switzerland
• Gaeltec Ltd., Isle of Skye, Scotland
• Harvard Medical School, Brigham and Women’s Hospital, MA, USA
• IGEA S.R.L., Carpi, Italy
• Institute Gustave-Roussy, Villejuif, Paris, France
• Johns Hopkins, The Sol Goldman Cancer Research Centre, Baltimore, USA
• Kings College London
• Mannheim University, Heidelberg, Germany
• Oncology Institute, Ljubljana, Slovenia
• UCLA
• University of Alberta, Edmonton, Canada
• University of Glasgow